BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) was the target of a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 4,285 shares, a drop of 47.3% from the June 30th total of 8,126 shares. Based on an average daily trading volume, of 2,510 shares, the short-interest ratio is currently 1.7 days.
BioSyent Trading Up 0.4%
Shares of BIOYF stock opened at $10.49 on Friday. The stock has a 50 day moving average of $10.15 and a two-hundred day moving average of $10.42. BioSyent has a 12 month low of $7.63 and a 12 month high of $12.00.
BioSyent Company Profile
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
See Also
- Five stocks we like better than BioSyent
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
